Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Invested Capital (2022 - 2023)

Cullinan Therapeutics (CGEM) has 2 years of Return on Invested Capital data on record, last reported at 0.51% in Q3 2023.

  • For Q3 2023, Return on Invested Capital changed N/A year-over-year to 0.51%; the TTM value through Sep 2023 reached 0.51%, changed N/A, while the annual FY2022 figure was 0.22%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.51% in Q3 2023 per CGEM's latest filing, down from 0.46% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.17% in Q2 2022 and bottomed at 0.51% in Q3 2023.